Use of Activated Recombinant Factor VII in Severe Bleeding – Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding

Publisher： Karger

E-ISSN： 1660-3818|39|2|139-150

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.39, Iss.2, 2012-03, pp. : 139-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Recombinant Factor VII as Rescue for Severe Perioperative Bleeding in HeartMate II Recipients

By  

JOURNAL OF CARDIAC SURGERY (ELECTRONIC), Vol. 30, Iss. 6, 2015-06 ,pp. : 500-505

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recombinant activated factor VII in paediatric cardiac surgery

By Egan Jonathan   Lammi Ahti   Schell David   Gillis Jonathan   Nunn Graham  

Intensive Care Medicine, Vol. 30, Iss. 4, 2004-04 ,pp. : 682-685

Springer Publishing Company

Access to resources Recommend Favorite

A Single Dose of Recombinant Activated Factor VII (NovoSeven®) Did Not Impair the Function of the Coronary Artery Bypass Grafts – Successful Treatment of Critical Bleeding after Cardiac Surgery in Two Cases

By  

Transfusion Medicine and Hemotherapy, Vol. 34, Iss. 3, 2007-05 ,pp. : 204-207

Karger

Access to resources Recommend Favorite

Experience with recombinant activated factor VII for severe post‐partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 8, 2015-08 ,pp. : 1161-1168

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recombinant Activated Factor VII as a General Haemostatic Agent:Evidence-Based Efficacy and Safety

By  

Current Drug Safety, Vol. 2, Iss. 2, 2007-05 ,pp. : 155-161

Bentham Science Publishers

Access to resources Recommend Favorite